Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Colorectal Neoplasms × Sulindac × Clear all

Phase

Status

Terminated 3 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Intraductal Neoplasms 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 30 Bevacizumab 28 Oxaliplatin 27 Leucovorin 26 Fluorouracil 25 Irinotecan 22 Cetuximab 21 Capecitabine 19 Nivolumab 17 Specimen Handling 12 atezolizumab 11 Panitumumab 11 regorafenib 10 trifluridine tipiracil drug combination 9 Paclitaxel 9 Carboplatin 9 Trifluridine 8 Colonoscopy 8 Biopsy 8 Aspirin 7 Standard of Care 6 Cisplatin 6 tislelizumab 5 balstilimab 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Immunoglobulin G 5 Gemcitabine 5 Folfox protocol 5 Early Intervention, Educational 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01349881 2026-04-02

PACES

SWOG Cancer Research Network

Phase 3 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡